Profile | GDS2987 / GI_16445353-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 18.5 | 53 |
GSM215244 | HMVEC_vehicle_rep2 | 13.2 | 33 |
GSM215253 | HMVEC_vehicle_rep3 | 25 | 59 |
GSM215254 | HMVEC_atorvastatin_rep1 | 25.1 | 53 |
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 27.3 | 54 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 24.3 | 43 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 2.9 | 6 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 30.3 | 45 |
GSM215294 | HMVEC_SLx2119_rep1 | 8.2 | 29 |
GSM215295 | HMVEC_SLx2119_rep2 | 29.5 | 50 |
GSM215296 | HMVEC_SLx2119_rep3 | 18.8 | 31 |
GSM215297 | PASMC_vehicle_rep1 | 11.2 | 17 |
GSM215298 | PASMC_vehicle_rep2 | 41.5 | 53 |
GSM215310 | PASMC_vehicle_rep3 | 9.1 | 15 |
GSM215311 | PASMC_atorvastatin_rep1 | 37.5 | 54 |
GSM215312 | PASMC_atorvastatin_rep2 | 35.5 | 49 |
GSM215313 | PASMC_atorvastatin_rep3 | 24 | 34 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 36.7 | 52 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 9.2 | 19 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 12.8 | 22 |
GSM215327 | PASMC_SLx2119_rep1 | 24.9 | 40 |
GSM215328 | PASMC_SLx2119_rep2 | 16.1 | 29 |
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 42.9 | 64 |
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 14 | 42 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 6.1 | 17 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 2.9 | 8 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 10.6 | 26 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 9 | 29 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 9.5 | 30 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 13.8 | 37 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 7.4 | 22 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 9.6 | 27 |
GSM215341 | Fibroblasts_SLx2119_rep3 |